Trials / Completed
CompletedNCT00785395
Up-Down Oxytocin Infusion
Up-down Determination of the ED90 of Oxytocin Infusions for the Prevention of Postpartum Uterine Atony in Parturients Undergoing Cesarean Delivery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- IWK Health Centre · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to determine the minimum effective dose (ED90) of infusions of oxytocin for the prevention of uterine atony / postpartum hemorrhage and the need for additional uterotonics, in low risk parturients presenting for an elective CD. The primary outcome measure is the response of effective uterine contraction as either satisfactory or unsatisfactory as determined by the obstetrician blinded to the oxytocin infusion dose. Secondary outcomes will include need for additional uterotonics, calculated intra-operative blood loss and presence of oxytocin related adverse effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin infusion | Up-down dosing determination |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2008-11-05
- Last updated
- 2011-11-02
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00785395. Inclusion in this directory is not an endorsement.